SCHEMBL20217541

SCHEMBL20217541

CN1C2CCC1CC(Oc1ccc(C(=N)c3cc(C(=O)NC(c4ccccc4)C(F)F)ccc3N)cc1)C2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.49
TTK P33981 1/20 0.49
AURKB Q96GD4 1/20 0.49
INCENP Q9NQS7 1/20 0.49
SLC6A2 P23975 2/20 0.43
SLC6A3 Q01959 1/20 0.43
OPRK1 P41145 7/20 0.42
KCNH2 Q12809 6/20 0.41
OPRM1 P35372 3/20 0.41
F10 P00742 3/20 0.38
LMNA P02545 3/20 0.38
CYP2D6 P10635 3/20 0.38
CYP2C9 P11712 2/20 0.38
HSD17B10 Q99714 1/20 0.38
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
CHRNA7 P36544 1/20 0.37
HTR3A P46098 1/20 0.37
HTR3D Q70Z44 1/20 0.37
HTR3C Q8WXA8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20217390 0.88 TTK (0.63) CYP3A4TTKAURKBINCENPSLC6A2
SCHEMBL20217361 0.86 HRH3 (0.43) CYP3A4TTKKCNH2LMNACHRM2
SCHEMBL20217664 0.83 CYP3A4 (0.47) CYP3A4TTKAURKBINCENPSLC6A2
SCHEMBL20217592 0.80 CYP3A4 (0.53) CYP3A4TTKAURKBINCENPSLC6A2
SCHEMBL20217349 0.79 CYP3A4 (0.50) CYP3A4TTKAURKBINCENPSLC6A2
SCHEMBL20217458 0.79 CYP3A4 (0.50) CYP3A4TTKAURKBINCENPSLC6A2
SCHEMBL20217755 0.78 CYP3A4 (0.47) CYP3A4TTKAURKBINCENPSLC6A2
SCHEMBL20217221 0.77 TTK (0.51) CYP3A4TTKAURKBINCENPF10
SCHEMBL20217781 0.77 CYP3A4 (0.41) CYP3A4TTKAURKBINCENPOPRK1
SCHEMBL16296497 0.77 TTK (0.80) CYP3A4TTKAURKBINCENP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2766352-B1 INDAZOLE COMPOUNDS AS KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME UNIV HEALTH NETWORK UHN (CA) 2018-06-06 EP disclosed